Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the ‘unclassifiable’

Current Opinion in Hematology · Published 2025-12-29 · DOI 10.1097/moh.0000000000000907

Authors being retrieved — see the publisher record. https://doi.org/10.1097/moh.0000000000000907

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Bidirectional relationship between metabolic and thrombotic disease mechanisms · Current Opinion in Hematology · 2026 · Same journal
• Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination · Current Opinion in Hematology · 2025 · Same journal
• The role of stem cell transplantation in the modern management of multiple myeloma · Current Opinion in Hematology · 2025 · Same journal
• Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology · Current Opinion in Hematology · 2026 · Same journal
• Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection · Current Opinion in Hematology · 2026 · Same journal
• Red cells: not only hemoglobin – plasma membranes are also of paramount importance · Current Opinion in Hematology · 2025 · Same journal
• Roles of megakaryocytes and platelets in myeloproliferative neoplasms · Current Opinion in Hematology · 2026 · Same journal
• Advances in the pathophysiology and treatment of anaemia in multiple myeloma · Current Opinion in Hematology · 2026 · Same journal
• G protein-coupled receptor-mediated platelet thrombus formation · Current Opinion in Hematology · 2026 · Same journal
• High-throughput genotyping tools for red blood cell antigens · Current Opinion in Hematology · 2025 · Same journal